Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 27, 2004 Filed Jan 28, 2004 22:02 UTC |
FRITZKY EDWARD VDirector
|
Exercise / conversionCommon Stock | 4,003 | $9.98 | $39,949.94 |
DisclosureSEC source: 0001181431-04-004977 · rrd30625.xml · nonDerivative · entry 1 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (EVF-1/27/04) Does not include (i) 528 shares indirectly held by son of reporting person, (ii) 528 shares indirectly held by daughter of reporting person, and (iii) as of December 31, 2003, 5,739.26 shares indirectly held by reporting person's 401(K) plan. Read SEC document |
| January 27, 2004 Filed Jan 28, 2004 23:02 UTC |
ODRE STEVEN MSr. VP, Gen. Counsel & Secy.
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 7,572 | $0.00 Strike: $14.14 | $0.00 |
DisclosureSEC source: 0001181431-04-005010 · rrd30544.xml · derivative · entry 3 ODRE STEVEN M · CIK 0001183886 · Sr. VP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,572 shares Expires 2004-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2004 Filed Jan 28, 2004 23:02 UTC |
ODRE STEVEN MSr. VP, Gen. Counsel & Secy.
|
SaleCommon Stock | 7,572 | $65.00 | $492,180.00 |
DisclosureSEC source: 0001181431-04-005010 · rrd30544.xml · nonDerivative · entry 2 ODRE STEVEN M · CIK 0001183886 · Sr. VP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,705 F1 · balance_after: (SMO 1/27/2004) The amount of the securities beneficially held by the reporting person (i) has been adjusted to reflect an acquisition of the Company's Common Stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(l)(k)(B) and (ii) does not include 4,852 shares held indirectly by the Charitable Remainder Trust (the "Trust"). The reporting person, who is the co-trustee pursuant to the terms of the Trust, is entitled to an annual percentage of the net fair market value of the assets of the Trust and hereby disclaims beneficial ownership, except to the extent of such interest. Read SEC document |
| January 27, 2004 Filed Jan 28, 2004 23:02 UTC |
ODRE STEVEN MSr. VP, Gen. Counsel & Secy.
|
Exercise / conversionCommon Stock | 7,572 | $14.14 | $107,073.38 |
DisclosureSEC source: 0001181431-04-005010 · rrd30544.xml · nonDerivative · entry 1 ODRE STEVEN M · CIK 0001183886 · Sr. VP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (SMO 1/27/2004) The amount of the securities beneficially held by the reporting person (i) has been adjusted to reflect an acquisition of the Company's Common Stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(l)(k)(B) and (ii) does not include 4,852 shares held indirectly by the Charitable Remainder Trust (the "Trust"). The reporting person, who is the co-trustee pursuant to the terms of the Trust, is entitled to an annual percentage of the net fair market value of the assets of the Trust and hereby disclaims beneficial ownership, except to the extent of such interest. Read SEC document |
| January 27, 2004 Filed Feb 9, 2005 17:33 UTC |
FRITZKY EDWARD VDirector
|
GiftCommon Stock | 4,003 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-008124 · rrd67895.xml · nonDerivative · entry 1 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,950 F1 · balance_after: (EVF 1.19.05) Does not include (i) 528 shares indirectly held by report person's son, (ii) 528 shares indirectly held by reporting person's daughter, and (iii) 5,677 shares indirectly held by reporting persons's 401(k) Plan as of January 19, 2005. Read SEC document |
| January 21, 2004 Filed Jan 21, 2004 21:48 UTC |
OMENN GILBERT SDirector
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 22,400 | $6.19 Strike: $6.19 | $138,600.00 |
DisclosureSEC source: 0001181431-04-003630 · rrd29679.xml · derivative · entry 3 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,400 shares Expires 2004-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2004 Filed Jan 21, 2004 21:48 UTC |
OMENN GILBERT SDirector
|
Tax withholdingCommon Stock | 2,201 | $62.95 | $138,552.95 |
DisclosureSEC source: 0001181431-04-003630 · rrd29679.xml · nonDerivative · entry 2 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,188 F1 · balance_after: (GSO-12/9/03) Does not included: (i) 5,250 shares held by the son of reporting person, and (ii) .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| January 21, 2004 Filed Jan 21, 2004 21:48 UTC |
OMENN GILBERT SDirector
|
Exercise / conversionCommon Stock | 22,400 | $6.19 | $138,600.00 |
DisclosureSEC source: 0001181431-04-003630 · rrd29679.xml · nonDerivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,389 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (GSO-12/9/03) Does not included: (i) 5,250 shares held by the son of reporting person, and (ii) .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| January 20, 2004 Filed Jan 21, 2004 21:42 UTC |
JOHNSON FRANKLIN P JRDirector
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 22,400 | $6.19 Strike: $6.19 | $138,600.00 |
DisclosureSEC source: 0001181431-04-003629 · rrd29625.xml · derivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,400 shares Expires 2004-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2004 Filed Jan 21, 2004 21:42 UTC |
JOHNSON FRANKLIN P JRDirector
|
Exercise / conversionCommon Stock | 22,400 | $6.19 | $138,600.00 |
DisclosureSEC source: 0001181431-04-003629 · rrd29625.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,048,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (FPJ 01.20.04) Does not include (i) 720,800 shares held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner, (ii) 4 units contractual contingent payment rights held as indirect ownership by the Partnership arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (iii) 872,416 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of the securities held by the Partnership and the securities held by the reporting person's spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for the purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| January 18, 2004 Filed Nov 19, 2004 00:27 UTC |
FENTON DENNIS MEx VP Ops & Corp Compliance
|
Exercise / conversionCommon Stock | 20,000 | $16.38 | $327,500.00 |
DisclosureSEC source: 0001181431-04-054055 · rrd58668.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 127,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| January 14, 2004 Filed Jan 15, 2004 17:33 UTC |
SEIDENBERG BETH CSr VP, Dev & Chief Medical Ofc
|
Tax withholdingCommon Stock | 1,858 | $64.05 | $119,004.90 |
DisclosureSEC source: 0001181431-04-002798 · rrd29162.xml · nonDerivative · entry 1 SEIDENBERG BETH C · CIK 0001184592 · Sr VP, Dev & Chief Medical Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,335 Read SEC document |
| December 09, 2003 Filed Dec 10, 2003 19:12 UTC |
OMENN GILBERT SDirector
|
GiftCommon Stock | 1,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-034913 · rrd25242.xml · nonDerivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,989 F1 · balance_after: (GSO-12/9/03) Does not include: (i) 5,250 shares held by the son of the reporting person, and (ii) .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| December 08, 2003 Filed Dec 9, 2003 21:23 UTC |
OMENN GILBERT SDirector
|
GiftCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-034777 · rrd25016.xml · nonDerivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,714 F1 · balance_after: (1) (GSO-12/8/03) Does not include: (i) 5,250 shares held by the son of reporting person, and (ii) .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 21, 2003 Filed Nov 21, 2003 23:19 UTC |
ODRE STEVEN MSr. VP, Gen. Counsel & Secy.
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $14.14 | $0.00 |
DisclosureSEC source: 0001181431-03-032431 · rrd23631.xml · derivative · entry 3 ODRE STEVEN M · CIK 0001183886 · Sr. VP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,572 Underlying: Common Stock · 15,000 shares Expires 2004-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2003 Filed Nov 21, 2003 23:19 UTC |
ODRE STEVEN MSr. VP, Gen. Counsel & Secy.
|
SaleCommon Stock | 15,000 | $60.26 | $903,825.00 |
DisclosureSEC source: 0001181431-03-032431 · rrd23631.xml · nonDerivative · entry 2 ODRE STEVEN M · CIK 0001183886 · Sr. VP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,199 F1 · balance_after: (SMO 11/21/03) Does not include 4,852 shares indirectly held by the Odre Charitable Remainder Trust (the "Trust"). The reporting person, who is the co-trustee pursuant to the terms of the Trust, is entitled to an annual percentage of the net fair market value of the assets of the Trust and hereby disclaims beneficial ownership, except to the extent of such interest. Read SEC document |
| November 21, 2003 Filed Nov 21, 2003 23:19 UTC |
ODRE STEVEN MSr. VP, Gen. Counsel & Secy.
|
Exercise / conversionCommon Stock | 15,000 | $14.14 | $212,110.50 |
DisclosureSEC source: 0001181431-03-032431 · rrd23631.xml · nonDerivative · entry 1 ODRE STEVEN M · CIK 0001183886 · Sr. VP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (SMO 11/21/03) Does not include 4,852 shares indirectly held by the Odre Charitable Remainder Trust (the "Trust"). The reporting person, who is the co-trustee pursuant to the terms of the Trust, is entitled to an annual percentage of the net fair market value of the assets of the Trust and hereby disclaims beneficial ownership, except to the extent of such interest. Read SEC document |
| November 21, 2003 Filed Nov 24, 2003 20:39 UTC |
LAZARUS STEVENDirector
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-032629 · rrd23602.xml · nonDerivative · entry 1 LAZARUS STEVEN · CIK 0001054117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,343 Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 10,000 | $60.20 | $601,990.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 15 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 872,416 Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 10,000 | $60.18 | $601,820.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 14 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 882,416 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 16,400 | $60.17 | $986,837.20 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 13 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 892,416 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 10,000 | $60.15 | $601,500.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 12 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 908,816 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 20,000 | $60.06 | $1,201,200.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 11 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 918,816 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 5,000 | $60.18 | $300,910.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 10 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 720,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 5,000 | $60.18 | $300,900.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 9 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 725,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 5,000 | $60.12 | $300,600.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 8 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 730,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 30,000 | $60.10 | $1,803,000.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 7 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 735,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 10,000 | $60.08 | $600,780.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 6 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 765,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 5,000 | $59.99 | $299,950.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 785,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 6,400 | $59.90 | $383,360.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 790,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 5,000 | $59.77 | $298,850.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 797,200 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 5,000 | $59.69 | $298,450.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 802,200 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 18, 2003 Filed Nov 20, 2003 00:02 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 10,000 | $60.05 | $600,500.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 5 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 775,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 10,000 | $59.48 | $594,750.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 14 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,025,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 5,000 | $59.45 | $297,250.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 13 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,035,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 5,000 | $59.43 | $297,130.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 12 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,040,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 5,000 | $59.41 | $297,050.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 11 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,045,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 5,000 | $59.40 | $297,000.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 10 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 5,000 | $59.36 | $296,800.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 9 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,055,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 15,000 | $59.30 | $889,500.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 8 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,060,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 10,000 | $59.29 | $592,900.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 7 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,075,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 10,000 | $59.25 | $592,500.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 6 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 6,000 | $59.20 | $355,200.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 5 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 5,000 | $59.19 | $295,950.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,101,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 5,000 | $59.10 | $295,500.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,106,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 5,000 | $58.90 | $294,500.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,111,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 5,000 | $58.80 | $294,000.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,116,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:33 UTC |
FRITZKY EDWARD VDirector
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 149,600 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0001181431-03-031434 · rrd22969.xml · derivative · entry 14 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 149,600 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:33 UTC |
FRITZKY EDWARD VDirector
|
SaleCommon Stock | 20,000 | $58.65 | $1,173,030.00 |
DisclosureSEC source: 0001181431-03-031434 · rrd22969.xml · nonDerivative · entry 13 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,728 F1 · balance_after: (EVF 11/03) Does not include (i) 528 shares indirectly held by reporting person's son, (ii) 528 shares indirectly held by reporting person's daughter, and (iii) 5,743.545 shares indirectly held by reporting person's 401(k) Plan. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:33 UTC |
FRITZKY EDWARD VDirector
|
SaleCommon Stock | 20,000 | $58.63 | $1,172,600.00 |
DisclosureSEC source: 0001181431-03-031434 · rrd22969.xml · nonDerivative · entry 12 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,728 F1 · balance_after: (EVF 11/03) Does not include (i) 528 shares indirectly held by reporting person's son, (ii) 528 shares indirectly held by reporting person's daughter, and (iii) 5,743.545 shares indirectly held by reporting person's 401(k) Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.